-
241
Immunotherapy as a neoadjuvant preoperative treatment for locally advanced pulmonary sarcomatoid carcinoma: a case report of clinical efficacy
Published 2025-01-01Subjects: Get full text
Article -
242
Real-world data of dacomitinib as first-line treatment for patients with EGFR-mutant non-small-cell lung cancer
Published 2025-02-01Subjects: “…Epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC)…”
Get full text
Article -
243
-
244
The antitumour efficacy of hesperidin vs. cisplatin against non‑small lung cancer cells A549 and H460 via targeting the miR‑34a/PD-L1/NF-κB signalling pathway
Published 2024-07-01Subjects: “…non-small cell lung cancer…”
Get full text
Article -
245
-
246
Pathological Complete Response to a Single Dose of Pembrolizumab‐Based Chemoimmunotherapy for Squamous Cell Carcinoma of the Lung: A Case Report
Published 2025-01-01Subjects: Get full text
Article -
247
Measurement of radon activity concentration in elementary schools in Tuzla, Bosnia and Herzegovina
Published 2024-01-01Subjects: Get full text
Article -
248
The potential of MRI radiomics based on extrapulmonary metastases in predicting EGFR mutations: a systematic review and meta-analysis
Published 2025-01-01Subjects: “…Non-small cell lung cancer…”
Get full text
Article -
249
Identification of prognostic biomarker of non-small cell lung cancer based on mitochondrial permeability transition-driven necrosis-related genes and determination of anti-tumor ef...
Published 2025-02-01Subjects: “…Non-small cell lung cancer…”
Get full text
Article -
250
Indocyanine green nebulization visualizes the pulmonary bronchus during video-assisted thoracoscopic surgery
Published 2025-02-01Subjects: “…Lung cancer…”
Get full text
Article -
251
-
252
The impact of PD-L1 expression status on the prognosis of ALK-positive lung cancer patients
Published 2024-01-01Subjects: “…Non-squamous non-small cell lung cancer…”
Get full text
Article -
253
Efficacy and safety of first-line nivolumab plus ipilimumab treatment in elderly patients (aged ≥ 75 years) with non-small cell lung cancer
Published 2025-01-01Subjects: “…Advanced non-small cell lung cancer…”
Get full text
Article -
254
Characteristics, treatment patterns, and biomarker testing of patients with advanced RET fusion-positive non-small cell lung cancer in a real-world multi-country observational stud...
Published 2025-02-01Subjects: “…RET fusion-positive non-small cell lung cancer…”
Get full text
Article -
255
-
256
The effect of baseline versus early glucocorticoid use on immune checkpoint inhibitor efficacy in patients with advanced NSCLC
Published 2025-01-01Subjects: Get full text
Article -
257
Efficacy and Safety Evaluation of Immune Checkpoint Inhibitors in Combination With Chemotherapy for Extensive Small Cell Lung Cancer: Real‐World Evidence
Published 2024-12-01Subjects: “…extensive‐stage small cell lung cancer…”
Get full text
Article -
258
Postoperative radiotherapy improves survival in completely resected non-small cell lung cancer with pathologic N2 stage IIIA and positive lymph node count greater than one: a SEER-...
Published 2025-02-01Subjects: “…non-small cell lung cancer…”
Get full text
Article -
259
-
260
CDK4/6 inhibitors promote PARP1 degradation and synergize with PARP inhibitors in non-small cell lung cancer
Published 2025-02-01Subjects: Get full text
Article